Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (111-120 of 302) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|June 5, 2017
Cost-effectiveness of opportunistic salpingectomy for ovarian cancer preventionSarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|August 10, 2010
SGO White Paper on ovarian cancer: etiology, screening and surveillanceJohn O Schorge, Susan C Modesitt, Robert L Coleman, et al.
Gynecologic Oncology|October 8, 2003
Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignanciesJason D Wright, Thomas J Herzog, David G Mutch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancerLeigh G Seamon, Matthew J Carlson, Debra L Richardson, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incisionGlenn M Updike, Tom P Manolitsas, David E Cohn, et al.
Oncogene|April 12, 2018
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteinsKalpana Deepa Priya Dorayappan, Ross Wanner, John J Wallbillich, et al.
Gynecologic Oncology|September 5, 2008
CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapyDebra L Richardson, Leigh G Seamon, Matthew J Carlson, et al.
Gynecologic Oncology|June 17, 2014
Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providersRobert Neff, Georgia A McCann, Kristen M Carpenter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Pageof 31

Showing results (111-120 of 302) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|June 5, 2017
Cost-effectiveness of opportunistic salpingectomy for ovarian cancer preventionSarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|August 10, 2010
SGO White Paper on ovarian cancer: etiology, screening and surveillanceJohn O Schorge, Susan C Modesitt, Robert L Coleman, et al.
Gynecologic Oncology|October 8, 2003
Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignanciesJason D Wright, Thomas J Herzog, David G Mutch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancerLeigh G Seamon, Matthew J Carlson, Debra L Richardson, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incisionGlenn M Updike, Tom P Manolitsas, David E Cohn, et al.
Oncogene|April 12, 2018
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteinsKalpana Deepa Priya Dorayappan, Ross Wanner, John J Wallbillich, et al.
Gynecologic Oncology|September 5, 2008
CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapyDebra L Richardson, Leigh G Seamon, Matthew J Carlson, et al.
Gynecologic Oncology|June 17, 2014
Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providersRobert Neff, Georgia A McCann, Kristen M Carpenter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Pageof 31